A Mulit-Centered Prospective Study of Quality of Life in Adult Scoliosis
成人脊柱侧凸生活质量的多中心前瞻性研究
基本信息
- 批准号:7731002
- 负责人:
- 金额:$ 48.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAdverse eventAffectAftercareAgeAge FactorsAmericanAnalgesicsAppearanceBack PainBody mass indexBone DensityCaringClinicalCohort StudiesComorbidityComplexDataDecision MakingDeformityDevelopmentDiseaseEducationEffectivenessElderlyEvidence based treatmentGenderGoalsGuidelinesHealth Care CostsHealthcareHospital CostsHospitalizationInferiorInjection of therapeutic agentInstitutionInterventionLifeLightLiteratureLiving WillsLumbar CurveMeasurementMeasuresMental HealthMethodsModelingNorth AmericaOlder PopulationOperative Surgical ProceduresOrthopedic Surgery proceduresOrthopedicsOutcomeOutcome StudyOutcomes ResearchPainPain in lower limbPathologyPatient CarePatient Outcomes AssessmentsPatientsPeer ReviewPhysical therapyPopulationPopulation StudyPractice ManagementPrevalenceProspective StudiesQuality of lifeRandomizedRandomized Controlled Clinical TrialsRandomized Controlled TrialsResearchResearch InfrastructureResearch PersonnelResearch SupportResourcesReview LiteratureRiskSF-12SeveritiesSocietiesSocioeconomic StatusSpeedSpinalSpinal CurvaturesTarget PopulationsTimeTreadmill TestsTreatment outcomeUpper armValidity of ResultsVertebral columnWalkingWorkagedaging populationarthropathiesburden of illnessclinical practicecohortcomparativecostdisabilityevidence baseexperiencefollow-uphealth related quality of lifeimprovedindexinginnovationinstrumentmemberpatient oriented researchpost interventionpredictive modelingpreferenceprospectivepublic health relevancescoliosistool
项目摘要
DESCRIPTION (provided by applicant): The goal of this patient-oriented study is to obtain health-related quality of life (HRQOL) outcomes data on patients who present with adult symptomatic lumbar scoliosis (ASLS) pre- and post-treatment in order to facilitate the development of evidence-based treatment guidelines, improve patient care and optimize healthcare resource utilization. We are defining ASLS as Oswestry Disability Index (ODI) e20, Scoliosis Research Society (SRS) domain scores d4.0 and a Cobb measurement of e300 at baseline. This study will help us determine how much the current treatment, either nonoperative or operative, improves the lives of people with this pathology. Significance: The impetus for this critical effort is the significant burden of disease posed by adult scoliosis, which affects 2.5-4% of the North American population. The most symptomatic group of primary presentation ASLS patients are those between the ages of 40 and 80 with lumbar deformities - our target population for this study. This disease constitutes a significant problem in light of our aging population and the high cost of surgical treatment (at least $80,000 in hospital costs alone). Studies to date, however, have typically been limited, small, single institution and retrospective. The extent to which treatment benefits patients with ASLS is not well established. Preliminary data: The Spinal Deformity Study Group/Adult Deformity Outcomes section (SDSG/ADO), which was formed 7 years ago, has developed a multi-center effort specifically to study adult scoliosis and has established an infrastructure for collecting consistent multicenter data. The SDSG has 1) validated a disease-specific outcomes tool (the SRS patient-reported outcomes instrument) for adult spinal deformity; 2) developed and validated disease-specific radiographic tools; 3) analyzed outcomes for certain interventions for comparison of treatments; and 4) collected preliminary data regarding the impact of treatments on patient outcomes. Methods: The study will comprise a multicenter, prospective, randomized controlled trial (RCT) (30%) and consecutive cohort study (70%) of patients receiving current standard-of-care treatments and will use uniform clinical and radiographic assessments that have been validated by our group for assessment of these patients. Both nonoperative and operative care will be standardized within the 5 centers. Quality of life will be assessed by SRS-QOL, ODI, SF-12, numerical rating scale (NRS) back pain and leg pain scores. Functional measures will include a walking treadmill test to assess speed and endurance in patients at baseline and 2 years post-treatment. Primary Aims: Measure the impacts and compare the outcomes of nonoperative and operative treatments in ASLS patients. Innovation: No outcomes study exists in any current peer-reviewed literature to document the effect of both nonoperative and operative treatment on any aspect of primary presentation adult spinal deformity. PUBLIC HEALTH RELEVANCE: The impetus for this critical effort is the significant burden of disease posed by adult symptomatic lumbar scoliosis (ASLS). This disease constitutes a growing problem in light of our aging population and the high cost of surgical treatment (at least $80,000 in hospital costs alone). Our study will facilitate the development of evidence-based treatment guidelines, improve patient care, and optimize healthcare resource utilization.
描述(由申请人提供):这项以患者为导向的研究的目标是获得治疗前后患有成人症状性腰椎侧弯(ASLS)的患者的健康相关生活质量(HRQOL)结果数据,以促进循证治疗指南的制定,改善患者护理并优化医疗保健资源利用。我们将ASLS定义为奥斯韦斯特里残疾指数(ODI)e20,脊柱侧凸研究协会(SRS)领域评分d4.0,基线时Cobb测量值e300。这项研究将帮助我们确定目前的治疗,无论是非手术还是手术,在多大程度上改善了这种病理的人的生活。重要性:这一关键努力的推动力是成人脊柱侧凸造成的重大疾病负担,该疾病影响了2.5-4%的北美人口。最有症状的ASLS患者是年龄在40 - 80岁之间的腰椎畸形患者-我们这项研究的目标人群。鉴于我国人口老龄化和手术治疗费用高昂(仅住院费用就至少80 000美元),这种疾病构成了一个重大问题。然而,迄今为止的研究通常是有限的,小型的,单一的机构和回顾性的。ASLS患者的治疗获益程度尚未完全确定。初步数据:7年前成立的脊柱畸形研究组/成人畸形结局部分(SDSG/ADO)专门开展了一项多中心研究,以研究成人脊柱侧凸,并建立了收集一致的多中心数据的基础设施。SDSG已1)确认了用于成人脊柱畸形的疾病特异性结局工具(SRS患者报告结局工具); 2)开发并确认了疾病特异性放射学工具; 3)分析了某些干预措施的结局,以比较治疗;以及4)收集了有关治疗对患者结局影响的初步数据。研究方法:该研究将包括一项多中心、前瞻性、随机对照试验(RCT)(30%)和连续队列研究(70%),研究对象为接受当前标准治疗的患者,并将使用经我们小组验证的统一临床和影像学评估来评估这些患者。非手术和手术护理将在5个中心内标准化。将通过SRS-QOL、ODI、SF-12、数字评定量表(NRS)背痛和腿痛评分评估生活质量。功能测量将包括步行跑步机测试,以评估基线和治疗后2年患者的速度和耐力。主要目的:测量非手术和手术治疗对ASLS患者的影响并比较其结局。创新:在目前的同行评审文献中没有任何结果研究来记录非手术和手术治疗对原发性成人脊柱畸形的任何方面的影响。公共卫生相关性:这一关键努力的动力是成人症状性腰椎侧凸(ASLS)造成的重大疾病负担。鉴于我国人口老龄化和手术治疗费用高昂(仅住院费用就至少8万美元),这种疾病构成了一个日益严重的问题。我们的研究将促进循证治疗指南的制定,改善患者护理,优化医疗资源利用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Keith Happ Bridwell其他文献
Keith Happ Bridwell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Keith Happ Bridwell', 18)}}的其他基金
A Mulit-Centered Prospective Study of Quality of Life in Adult Scoliosis
成人脊柱侧凸生活质量的多中心前瞻性研究
- 批准号:
7914150 - 财政年份:2009
- 资助金额:
$ 48.33万 - 项目类别:
A Mulit-Centered Prospective Study of Quality of Life in Adult Scoliosis
成人脊柱侧凸生活质量的多中心前瞻性研究
- 批准号:
8323823 - 财政年份:2009
- 资助金额:
$ 48.33万 - 项目类别:
A Mulit-Centered Prospective Study of Quality of Life in Adult Scoliosis
成人脊柱侧凸生活质量的多中心前瞻性研究
- 批准号:
8137128 - 财政年份:2009
- 资助金额:
$ 48.33万 - 项目类别:
A Mulit-Centered Prospective Study of Quality of Life in Adult Scoliosis
成人脊柱侧凸生活质量的多中心前瞻性研究
- 批准号:
8727256 - 财政年份:2009
- 资助金额:
$ 48.33万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 48.33万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 48.33万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 48.33万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 48.33万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 48.33万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 48.33万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 48.33万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 48.33万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 48.33万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 48.33万 - 项目类别: